Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Osmolality Measurement in Sterile Products – V 2.0

Posted on By

Analytical Method Development: SOP for Osmolality Measurement in Sterile Products – V 2.0

Standard Operating Procedure for Osmolality Measurement in Sterile Products in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/269/2025
Supersedes SOP/AMD/269/2022
Page No. Page 1 of 11
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To outline a validated procedure for determining the osmolality of sterile injectable pharmaceutical products using a freezing point depression osmometer, to ensure formulation safety, comfort, and compatibility with physiological

conditions.

2. Scope

This SOP is applicable to the Analytical Method Development (AMD) and Quality Control (QC) departments for the analysis and validation of osmolality measurements in parenteral dosage forms, including solutions, emulsions, and suspensions.

3. Responsibilities

  • Analytical Scientist: Performs osmolality testing using a calibrated osmometer and documents results.
  • QC Analyst: Prepares test samples and reference standards for measurement.
  • QA Executive: Reviews test records and ensures adherence to regulatory and compendial requirements.
See also  Analytical Method Development: SOP for Documentation Review Before Report Finalization - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring the method is validated, suitable for intended use, and compliant with pharmacopeial standards.

5. Procedure

5.1 Principle

Osmolality is measured based on the depression of the freezing point of a solution relative to pure solvent, expressed in milliosmoles per kilogram of water (mOsm/kg H2O).

5.2 Equipment and Materials

  1. Freezing Point Depression Osmometer (e.g., Advanced Instruments or equivalent)
  2. Calibrated osmolality reference standards (100, 290, and 1000 mOsm/kg)
  3. Sterile syringes, vials, and sample tubes

5.3 Calibration

  1. Calibrate osmometer using three-point standardization (100, 290, 1000 mOsm/kg) before use (Annexure-2).
  2. Acceptable recovery: ±2% of nominal value.
  3. Recalibrate daily or after 20 consecutive runs.

5.4 Sample Preparation

  1. Use 100–250 µL of the injection sample directly or diluted as per formulation requirement.
  2. Degas or equilibrate to room temperature (20–25°C) before analysis.
  3. Handle under aseptic conditions to avoid contamination.

5.5 Test Execution

  1. Clean the sample probe with WFI and wipe dry before and after each test.
  2. Aspirate the sample into the sample holder using a micropipette.
  3. Insert into the osmometer; initiate automatic freezing and readout.
  4. Document osmolality value in mOsm/kg with sample ID, batch number, and operator initials.
See also  Analytical Method Development: Determination of Absorptivity Values - V 2.0

5.6 Acceptance Criteria

  • Isotonic range: 270–310 mOsm/kg H2O (physiological tolerance)
  • For hypertonic/hypotonic products, permissible range defined in product specification dossier
  • Deviation from specification requires justification and impact assessment on safety/efficacy

5.7 Method Validation Parameters

  1. Accuracy: Recovery within ±2% of standard values
  2. Precision: RSD ≤1.5% over 6 replicate injections
  3. Linearity: r² ≥ 0.999 between 100–1000 mOsm/kg
  4. Robustness: Test reproducibility under temperature and time delays

6. Abbreviations

  • QA: Quality Assurance
  • WFI: Water for Injection
  • RSD: Relative Standard Deviation
  • mOsm/kg: Milliosmoles per Kilogram

7. Documents

  1. Osmolality Test Log – Annexure-1
  2. Calibration Certificate – Annexure-2
  3. Validation Summary Report – Annexure-3

8. References

  • USP <785>: Osmolality and Osmolarity
  • Ph. Eur. 2.2.35: Osmolality
  • ICH Q2(R1): Validation of Analytical Procedures

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Anuradha Tiwari Mahesh Pillai Sunita Reddy
Designation Senior Analyst QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Osmolality Test Log

Sample ID Batch No. Volume Tested (µL) Osmolality (mOsm/kg) Status
INJ-269-01 21052302 100 288 Pass

Annexure-2: Calibration Certificate

Standard Value (mOsm/kg) Observed Value Recovery (%) Status
100 99.2 99.2% Pass
290 292.5 100.9% Pass
1000 1003 100.3% Pass

Annexure-3: Validation Summary Report

The osmolality method for injectable formulations including sodium chloride injection and multivitamin preparations was validated. Accuracy (99–101%), precision (RSD = 1.2%), and robustness across multiple analysts were confirmed. Method approved for routine QC and stability programs.

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Updated calibration procedure and validation parameters Annual Review Sunita Reddy
20/03/2022 1.0 Initial SOP Release New SOP QA Head
See also  Analytical Method Development: SOP for Identification of Objectionable Microorganisms - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Gel Manufacturing: SOP for Production of Thermosensitive Gels – V 2.0
Next Post: CAPA Records Without Reference to Originating Failures: A Hidden GMP Risk

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version